Literature DB >> 22021706

Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.

Miao Lin1, Wai Han Yiu, Hao Jia Wu, Loretta Y Y Chan, Joseph C K Leung, Wo Shing Au, Kwok Wah Chan, Kar Neng Lai, Sydney C W Tang.   

Abstract

Inflammation contributes to the tubulointerstitial lesions of diabetic nephropathy. Toll-like receptors (TLRs) modulate immune responses and inflammatory diseases, but their role in diabetic nephropathy is not well understood. In this study, we found increased expression of TLR4 but not of TLR2 in the renal tubules of human kidneys with diabetic nephropathy compared with expression of TLR4 and TLR2 in normal kidney and in kidney disease from other causes. The intensity of tubular TLR4 expression correlated directly with interstitial macrophage infiltration and hemoglobin A1c level and inversely with estimated glomerular filtration rate. The tubules also upregulated the endogenous TLR4 ligand high-mobility group box 1 in diabetic nephropathy. In vitro, high glucose induced TLR4 expression via protein kinase C activation in a time- and dose-dependent manner, resulting in upregulation of IL-6 and chemokine (C-C motif) ligand 2 (CCL-2) expression via IκB/NF-κB activation in human proximal tubular epithelial cells. Silencing of TLR4 with small interfering RNA attenuated high glucose-induced IκB/NF-κB activation, inhibited the downstream synthesis of IL-6 and CCL-2, and impaired the ability of conditioned media from high glucose-treated proximal tubule cells to induce transmigration of mononuclear cells. We observed similar effects using a TLR4-neutralizing antibody. Finally, streptozotocin-induced diabetic and uninephrectomized TLR4-deficient mice had significantly less albuminuria, renal dysfunction, renal cortical NF-κB activation, tubular CCL-2 expression, and interstitial macrophage infiltration than wild-type animals. Taken together, these data suggest that a TLR4-mediated pathway may promote tubulointerstitial inflammation in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22021706      PMCID: PMC3269929          DOI: 10.1681/ASN.2010111210

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  63 in total

1.  Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia.

Authors:  Melvyn Lynn; Daniel P Rossignol; Janice L Wheeler; Richard J Kao; Carlos A Perdomo; Robert Noveck; Ramon Vargas; Tony D'Angelo; Sandra Gotzkowsky; F Gilbert McMahon
Journal:  J Infect Dis       Date:  2003-02-07       Impact factor: 5.226

2.  Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.

Authors:  F Y Chow; D J Nikolic-Paterson; E Ozols; R C Atkins; B J Rollin; G H Tesch
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

3.  Increased expression of toll-like receptor 2 in rat diabetic nephropathy.

Authors:  Fanglin Li; Niansheng Yang; Lili Zhang; Hechang Tan; Bin Huang; Yingjie Liang; Miaoyan Chen; Xueqing Yu
Journal:  Am J Nephrol       Date:  2010-07-14       Impact factor: 3.754

4.  HMGB1 contributes to kidney ischemia reperfusion injury.

Authors:  Huiling Wu; Jin Ma; Peng Wang; Theresa M Corpuz; Usha Panchapakesan; Kate R Wyburn; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 10.121

5.  Involvement of PKCalpha/beta in TLR4 and TLR2 dependent activation of NF-kappaB.

Authors:  Karim Asehnoune; Derek Strassheim; Sanchayita Mitra; Jae Yeol Kim; Edward Abraham
Journal:  Cell Signal       Date:  2005-03       Impact factor: 4.315

6.  Renoprotection by rosiglitazone in accelerated type 2 diabetic nephropathy: Role of STAT1 inhibition and nephrin restoration.

Authors:  Sydney C W Tang; Joseph C K Leung; Loretta Y Y Chan; Amy Shan Cheng; Hui Yao Lan; Kar Neng Lai
Journal:  Am J Nephrol       Date:  2010-07-01       Impact factor: 3.754

7.  Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors.

Authors:  Mohan R Dasu; Ishwarlal Jialal
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-19       Impact factor: 4.310

8.  Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites.

Authors:  Tzvetanka Bondeva; Thierry Roger; Gunter Wolf
Journal:  Am J Nephrol       Date:  2007-05-08       Impact factor: 3.754

9.  Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.

Authors:  V Ninichuk; O Kulkarni; S Clauss; H -J Anders
Journal:  Eur J Med Res       Date:  2007-08-16       Impact factor: 2.175

10.  High glucose induces toll-like receptor expression in human monocytes: mechanism of activation.

Authors:  Mohan R Dasu; Sridevi Devaraj; Ling Zhao; Daniel H Hwang; Ishwarlal Jialal
Journal:  Diabetes       Date:  2008-07-23       Impact factor: 9.461

View more
  124 in total

1.  Paeoniflorin Suppressed High Glucose-Induced Retinal Microglia MMP-9 Expression and Inflammatory Response via Inhibition of TLR4/NF-κB Pathway Through Upregulation of SOCS3 in Diabetic Retinopathy.

Authors:  Su-Hua Zhu; Bing-Qian Liu; Mao-Juan Hao; Yi-Xin Fan; Cheng Qian; Peng Teng; Xiao-Wei Zhou; Liang Hu; Wen-Tao Liu; Zhi-Lan Yuan; Qing-Ping Li
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

2.  Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.

Authors:  Jay C Jha; Aozhi Dai; Chet E Holterman; Mark E Cooper; Rhian M Touyz; Chris R Kennedy; Karin A M Jandeleit-Dahm
Journal:  Diabetologia       Date:  2019-06-20       Impact factor: 10.122

3.  High-mobility group box 1 inhibits HCO3- absorption in the medullary thick ascending limb through RAGE-Rho-ROCK-mediated inhibition of basolateral Na+/H+ exchange.

Authors:  Bruns A Watts; Thampi George; Andrew Badalamenti; David W Good
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-29

4.  Peptidomic Analysis of Urine from Youths with Early Type 1 Diabetes Reveals Novel Bioactivity of Uromodulin Peptides In Vitro.

Authors:  Julie A D Van; Sergi Clotet-Freixas; Joyce Zhou; Ihor Batruch; Chunxiang Sun; Michael Glogauer; Luca Rampoldi; Yesmino Elia; Farid H Mahmud; Etienne Sochett; Eleftherios P Diamandis; James W Scholey; Ana Konvalinka
Journal:  Mol Cell Proteomics       Date:  2019-12-26       Impact factor: 5.911

5.  Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy.

Authors:  Harmeet Kaur; Alexander Chien; Ishwarlal Jialal
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-08

Review 6.  How the Innate Immune System Senses Trouble and Causes Trouble.

Authors:  Takashi Hato; Pierre C Dagher
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-20       Impact factor: 8.237

7.  A two-hit mechanism for sepsis-induced impairment of renal tubule function.

Authors:  Bruns A Watts; Thampi George; Edward R Sherwood; David W Good
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-16

8.  Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.

Authors:  Jin Ma; Huiling Wu; Cathy Y Zhao; Usha Panchapakesan; Carol Pollock; Steven J Chadban
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 9.  Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

Authors:  Kristen Renee McSweeney; Laura Kate Gadanec; Tawar Qaradakhi; Benazir Ashiana Ali; Anthony Zulli; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

Review 10.  Can we target tubular damage to prevent renal function decline in diabetes?

Authors:  Joseph V Bonventre
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.